Literature DB >> 29502800

Paternal exposure to antirheumatic drugs-What physicians should know: Review of the literature.

M C Micu1, M Ostensen2, P M Villiger3, R Micu4, R Ionescu5.   

Abstract

Reproduction capacity and long-term preserved hormonal function are important aspects with big impacts on patients' quality of life. Updated information on the interaction between drug therapy and reproductive function is essential when discussing family planning with patients. Currently, limited data is published regarding paternal exposure to different medications. Thus, it may be a challenge for the practitioner to choose the right therapy for a young male patient. Therefore we reviewed the literature, for effects of antirheumatic drugs on male gonadal function with a focus on spermatogenesis and offspring.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antirheumatic drugs; Biologic therapy; DMARDs; Fertility; Offspring outcome; Paternal exposure; Pregnancy outcome; Sperm parameters

Mesh:

Substances:

Year:  2018        PMID: 29502800     DOI: 10.1016/j.semarthrit.2018.01.006

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  3 in total

1.  Reproductive rheumatology: the male perspective.

Authors:  Timo Tolppa; Isabella Plumptre; Maria Mouyis
Journal:  Clin Rheumatol       Date:  2019-02-13       Impact factor: 2.980

2.  Real-world questions and concerns about disease-modifying antirheumatic drugs (DMARDs): a retrospective analysis of questions to a medicine call center.

Authors:  Hiba El Masri; Samantha A Hollingworth; Mieke van Driel; Helen Benham; Treasure M McGuire
Journal:  BMC Rheumatol       Date:  2020-06-16

3.  Mapping the past, present and future research landscape of paternal effects.

Authors:  Joanna Rutkowska; Malgorzata Lagisz; Russell Bonduriansky; Shinichi Nakagawa
Journal:  BMC Biol       Date:  2020-11-27       Impact factor: 7.431

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.